UFPT vs WST
UFPT: UFP Technologies is a custom-engineered component manufacturer providing specialized solutions primarily for the medical device and healthcare industries. WST: West Pharmaceutical Services provides essential high-quality, sterile packaging and delivery systems for injectable medications globally.
Side-by-side fundamentals
| Metric | UFPT | WST | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $286.56 | $363.27 | |
| Market cap | $2.2B | $25.6B | |
| P/E as of 2026-10-08 | 30.95 | 46.44 | UFPT lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 1.81 | n/a | |
| Net margin FY2025, SEC XBRL | +11.3% | +16.1% | WST higher |
| Gross margin FY2025, SEC XBRL | +28.3% | +35.9% | WST higher |
| Operating margin FY2025, SEC XBRL | +15.3% | +19.0% | WST higher |
| ROE FY2025, SEC XBRL | +16.1% | +15.5% | UFPT higher |
| ROA FY2025, SEC XBRL | +10.4% | +11.6% | WST higher |
| Debt / equity as of 2026-09-02 | 0.25 | 0.07 | WST lower |
| Revenue growth (YoY) as of 2026-09-02 | +7.3% | +12.4% | WST higher |
| Revenue CAGR (3y) SEC XBRL | +22.7% | +2.1% | UFPT higher |
| Dividend yield as of 2026-09-02 | n/a | +0.2% | |
| Dividend streak (yrs) SEC XBRL | 0 | 15 | WST higher |
| Beta as of 2026-09-02 | 1.04 | 0.59 | |
| 1-year return as of 2026-10-08 close | +45.9% | +35.6% | UFPT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.